Re Advisers »

Cytokinetics shares owned by Re Advisers

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Re Advisers from 13F filings

Historical chart of Re Advisers investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Re Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Re Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 23k 85.19

More positions owned by Re Advisers

JPMorgan Chase & Co. (JPM)
Lam Research Corp Com New (LRCX)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Abbvie (ABBV)
Parker-Hannifin Corporation (PH)
Alphabet Cap Stk Cl C (GOOG)
Deere & Company (DE)
UnitedHealth (UNH)
Goldman Sachs (GS)
Amazon (AMZN)
Cisco Systems (CSCO)
Eaton Corp SHS (ETN)
Wal-Mart Stores (WMT)
Royalty Pharma Shs Class A (RPRX)

View all positions for Re Advisers

Top funds holding Cytokinetics

BlackRock
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
venBio Select Advisor
Bank of America Corporation
Susquehanna International
Geode Capital Management
Rtw Investments
Armistice Capital
Polar Capital Holdings
Citadel Advisors
Goldman Sachs Group

View all funds holding Cytokinetics